India · Delayed Price · Currency is INR RPG Life Sciences Statistics
Total Valuation
BOM:532983 has a market cap or net worth of INR 32.66 billion. The enterprise value is 30.42 billion.
| Market Cap | 32.66B |
| Enterprise Value | 30.42B |
Important Dates
The last earnings date was Tuesday, January 27, 2026.
| Earnings Date | Jan 27, 2026 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
| Current Share Class | 16.54M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 54.16% |
| Owned by Institutions (%) | 9.48% |
| Float | 4.29M |
Valuation Ratios
The trailing PE ratio is 16.12.
| PE Ratio | 16.12 |
| Forward PE | n/a |
| PS Ratio | 4.85 |
| PB Ratio | 5.90 |
| P/TBV Ratio | 6.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 15.01 |
| EV / Sales | 4.52 |
| EV / EBITDA | 21.06 |
| EV / EBIT | 25.40 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 176.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 29.51% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 5.06M |
| Profits Per Employee | 1.52M |
| Employee Count | 1,331 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532983 has paid 462.80 million in taxes.
| Income Tax | 462.80M |
| Effective Tax Rate | 18.59% |
Stock Price Statistics
The stock price has decreased by -14.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -14.31% |
| 50-Day Moving Average | 2,211.12 |
| 200-Day Moving Average | 2,294.10 |
| Relative Strength Index (RSI) | 34.62 |
| Average Volume (20 Days) | 1,072 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532983 had revenue of INR 6.74 billion and earned 2.03 billion in profits. Earnings per share was 122.51.
| Revenue | 6.74B |
| Gross Profit | 4.28B |
| Operating Income | 1.20B |
| Pretax Income | 2.49B |
| Net Income | 2.03B |
| EBITDA | 1.44B |
| EBIT | 1.20B |
| Earnings Per Share (EPS) | 122.51 |
Balance Sheet
The company has 2.24 billion in cash and n/a in debt, with a net cash position of 2.24 billion.
| Cash & Cash Equivalents | 2.24B |
| Total Debt | n/a |
| Net Cash | 2.24B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.54B |
| Book Value Per Share | 334.93 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 63.57%, with operating and profit margins of 17.78% and 30.07%.
| Gross Margin | 63.57% |
| Operating Margin | 17.78% |
| Pretax Margin | 36.94% |
| Profit Margin | 30.07% |
| EBITDA Margin | 21.39% |
| EBIT Margin | 17.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 1.22%.
| Dividend Per Share | 24.00 |
| Dividend Yield | 1.22% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.22% |
| Earnings Yield | 6.20% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |